Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know

Novavax (NVAX) closed at $93.13 in the latest trading session, marking a -0.49% move from the prior day.

NVAX : 93.13 (-0.49%)
Look for Shares of Novavax Inc to Potentially Rebound after Yesterday's 3.15% Sell Off

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $86.45 to a high of $92.87. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $88.91...

NVAX : 93.13 (-0.49%)
Endo (ENDP) Gains on Deal to Acquire BioSpecifics for $540M

Endo (ENDP) gains from the acquisition of commercial-stage biopharmaceutical company, BioSpecifics Technologies Corp.

ENDP : 5.79 (unch)
VRTX : 211.58 (+0.71%)
NVAX : 93.13 (-0.49%)
BSTC : 88.16 (+0.05%)
Novavax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2020

GAITHERSBURG, Md., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...

NVAX : 93.13 (-0.49%)
Novavax Inc Falls 2.80% on Heavy Volume: Watch For Potential Rebound

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $100.40 to a high of $107.94. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $106.01...

NVAX : 93.13 (-0.49%)
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know

Novavax (NVAX) closed at $111.42 in the latest trading session, marking a -0.3% move from the prior day.

NVAX : 93.13 (-0.49%)
US Vaccine Market Size, Growth, Opportunity, Forecast and Covid-19 Impact Analysis to 2025

Brandessece Market Research recently added the research report which offers a thorough study of the market scenario regarding the market size, share, demand, growth, trends, and forecast from 2020-2026....

BMY : 60.13 (-1.04%)
CSLLY : 105.6800 (-0.55%)
DSNKY : 25.6800 (-0.19%)
DVAX : 4.16 (-0.95%)
MRK : 79.83 (+0.78%)
NVAX : 93.13 (-0.49%)
PFE : 38.18 (+2.00%)
SVA : 6.47 (-0.31%)
VRX.TO : 30.80 (-3.33%)
VBIV : 2.55 (-2.30%)
Vaxart (VXRT) Begins Dosing in Oral Coronavirus Vaccine Study

Vaxart (VXRT) doses the first subject in an early-stage study of its oral coronavirus vaccine candidate VXA-CoV2-1. Stock rises.

MRNA : 70.53 (-0.44%)
NVAX : 93.13 (-0.49%)
VXRT : 5.64 (+3.49%)
CVAC : 50.03 (+1.96%)
Novavax Inc Set to Possibly Pullback After Yesterday's Rally of 8.24%

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $111.00 to a high of $120.55. Yesterday, the shares gained 8.2%, which took the trading range above the 3-day high of...

NVAX : 93.13 (-0.49%)
Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure

-- Team will focus on global NanoFlu licensure and evaluation of post-pandemic influenza/COVID-19 combination vaccine with NVX-CoV2373

NVAX : 93.13 (-0.49%)
Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Novavax (NVAX) closed at $111.02, marking a +0.93% move from the previous day.

NVAX : 93.13 (-0.49%)
Novavax Inc Set to Possibly Pullback After Yesterday's Rally of 3.09%

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $109.45 to a high of $114.31. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of...

NVAX : 93.13 (-0.49%)
4 Biotech Stocks Benefiting from Trump’s COVID-19 Diagnosis

As news spread that the President received treatment with drugs from Regeneron Pharmaceuticals (REGN) and Gilead Sciences (GILD), the biotech sector soared. This could lead to further gains in the sector...

REGN : 579.81 (+0.71%)
GILD : 60.79 (+0.20%)
NVAX : 93.13 (-0.49%)
MRNA : 70.53 (-0.44%)
Small-Caps, Energy Win the Trading Day

The Energy sector was one of the biggest winners on the day, coming after weeks of hard-hit commodity prices finally getting a little traction.

NVAX : 93.13 (-0.49%)
BNTX : 88.69 (+2.70%)
Novavax to Participate in Upcoming Conferences

GAITHERSBURG, Md., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Novavax Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...

NVAX : 93.13 (-0.49%)
Biotech Stock Roundup: REGN's Cocktail Data, GILD's RA Drug Approval & Other Updates

The biotech sector remains in focus with regulatory and other pipeline updates.

REGN : 579.81 (+0.71%)
GILD : 60.79 (+0.20%)
VRTX : 211.58 (+0.71%)
NVAX : 93.13 (-0.49%)
MYOV : 15.82 (+2.33%)
CVAC : 50.03 (+1.96%)
SmarTrend Watching for Potential Rebound in Shares of Novavax Inc After 5.82% Loss

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $103.10 to a high of $109.33. Yesterday, the shares fell 5.8%, which took the trading range below the 3-day low of $105.08...

NVAX : 93.13 (-0.49%)
Rising Incidence Of Viral Diseases And Increase In Elderly Population Are Causing Growth In The Anti-Viral Drug Therapy Market Size

(Anti-Viral Drug Therapy Companies Included: AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy's...

ABT : 107.79 (-1.54%)
ABBV : 84.34 (+0.04%)
AZN : 52.00 (+0.08%)
BCRX : 3.71 (-3.39%)
GILD : 60.79 (+0.20%)
GSK : 35.29 (+0.57%)
INO : 10.95 (-2.58%)
MRK : 79.83 (+0.78%)
NVAX : 93.13 (-0.49%)
PFE : 38.18 (+2.00%)
REGN : 579.81 (+0.71%)
Novavax (NVAX) Gains But Lags Market: What You Should Know

Novavax (NVAX) closed at $108.35 in the latest trading session, marking a +0.37% move from the prior day.

NVAX : 93.13 (-0.49%)
CureVac Begins Phase IIa Study on Coronavirus Vaccine Candidate

CureVac (CVAC) doses the first patient in a phase IIa study on its COVID-19 vaccine candidate CVnCoV. Shares rise in after-hours trading following this development.

MRNA : 70.53 (-0.44%)
NVAX : 93.13 (-0.49%)
VXRT : 5.64 (+3.49%)
CVAC : 50.03 (+1.96%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar